FLAVIO GALVAO

Prof. Dr. FLAVIO GALVAO

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2008 in The American Journal of Surgery
Verified
Journal Article
Closed access
MMMarcel Autran C. Machado
Marcel Autran C. Machado
FMFabio F. Makdissi
Fabio F. Makdissi
FGFLAVIO GALVAO
FLAVIO GALVAO
MMMarcel C.C. Machado
Marcel C.C. Machado

1 August 2012 in Acta Cirurgica Brasileira
Verified
Journal Article
Open access
PDF file
TMThamirys Guimarães Marques
Thamirys Guimarães Marques
ECEleazar Chaib
Eleazar Chaib
JFJuliana Hamati da Fonseca
Juliana Hamati da Fonseca
ALAna Cecília Rodrigues Lourenço
Ana Cecília Rodrigues Lourenço
FSFelipe Duarte Silva
Felipe Duarte Silva
LDLuiz Augusto Carneiro D'Albuquerque
Luiz Augusto Carneiro D'Albuquerque
PURPOSE: To present a review about a comparative study of bile duct ligation versus carbon tetrachloride Injection for inducing experimental liver cirrhosis. METHODS: This research was made through Medline/PubMed and SciELO web sites looking for papers on the content "induction of liver cirrhosis in rats". We have found 107 articles but only 30 were selected from 2004 to 2011. RESULTS: The most common methods used for inducing liver cirrhosis in the rat were administration of carbon tetrachloride (CCl4) and bile duct ligation (BDL). CCl4 has induced cirrhosis from 36 hours to 18 weeks after injection and BDL from seven days to four weeks after surgery. CONCLUSION: For a safer inducing cirrhosis method BDL is better than CCl4 because of the absence of toxicity for researches and shorter time for achieving it.

2 July 2013 in Surgical and Radiologic Anatomy
Verified
Journal Article
Closed access
PDF file
ECEleazar Chaib
Eleazar Chaib
AKAlexandre Fligelman Kanas
Alexandre Fligelman Kanas
FGFLAVIO GALVAO
FLAVIO GALVAO
LDLuiz Augusto Carneiro D’aLbuquerque
Luiz Augusto Carneiro D’aLbuquerque

1 January 2020 in Clinics
Verified
Journal Article
Open access
PDF file
LNLucas Souto Nacif
Lucas Souto Nacif
LZLeonardo Y. Zanini
Leonardo Y. Zanini
DWDaniel R. Waisberg
Daniel R. Waisberg
RPRafael S. Pinheiro
Rafael S. Pinheiro
FGFLAVIO GALVAO
FLAVIO GALVAO
LDLuiz Carneiro D'ALbuquerque
Luiz Carneiro D'ALbuquerque
Coronavirus disease (COVID-19) rapidly progresses to severe acute respiratory syndrome. This review aimed at collating available data on COVID-19 infection in solid organ transplantation (SOT) patients. We performed a systematic review of SOT patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The MEDLINE and PubMed databases were electronically searched and updated until April 20, 2020. The MeSH terms used were “COVID-19” AND “Transplant.” Thirty-nine COVID-19 cases were reported among SOT patients. The median interval for developing SARS-CoV-2 infection [...] Coronavirus disease (COVID-19) rapidly progresses to severe acute respiratory syndrome. This review aimed at collating available data on COVID-19 infection in solid organ transplantation (SOT) patients. We performed a systematic review of SOT patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The MEDLINE and PubMed databases were electronically searched and updated until April 20, 2020. The MeSH terms used were “COVID-19” AND “Transplant.” Thirty-nine COVID-19 cases were reported among SOT patients. The median interval for developing SARS-CoV-2 infection

1 December 2005 in Transplantation Proceedings
Verified
Journal Article
Closed access
FGFLAVIO GALVAO
FLAVIO GALVAO
ABA. Bakonyi-Neto
A. Bakonyi-Neto
MMM.A.C. Machado
M.A.C. Machado
AFA.Q. Farias
A.Q. Farias
EME.S. Mello
E.S. Mello
MMM.C.C. Machado
M.C.C. Machado

25 September 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KHKarin M. van der Heijden
Karin M. van der Heijden
IHInneke M. van der Heijden
Inneke M. van der Heijden
FGFLAVIO GALVAO
FLAVIO GALVAO
CLCamila G. Lopes
Camila G. Lopes
SCSilvia F. Costa
Silvia F. Costa
ALAnna S. Levin
Anna S. Levin
The objectives of this study were to develop a rat model of gastrointestinal colonization with vancomycin-resistant Enterococcus faecalis (VRE) and extended-spectrum beta-lactamase (ESBL)-producing E. coli and to evaluate intestinal translocation to blood and tissues after total and partial hepatic ischemia. Methods - We developed a model of rat colonization with VRE and ESBL-E coli. Then we studied four groups of colonized rats: Group I (with hepatic pedicle occlusion causing complete liver ischemia and intestinal stasis); Group II (with partial liver ischemia without intestinal stasis); Group III (surgical manipulation without hepatic ischemia or intestinal stasis); Group IV (anesthetized without surgical manipulation). After sacrifice, portal and systemic blood, large intestine, small intestine, spleen, liver, lungs, and cervical and mesenteric lymph nodes were cultured. Endotoxin concentrations in portal and systemic blood were determined. Results – The best inocula were: VRE: 2.4×1010 cfu and ESBL-E. coli: 1.12×1010 cfu. The best results occurred 24 hours after inoculation and antibiotic doses of 750 µg/mL of water for vancomycin and 2.1 mg/mL for ceftriaxone. There was a significantly higher proportion of positive cultures for ESBL-E. coli in the lungs in Groups I, II and III when compared with Group IV (67%; 60%; 75% and 13%, respectively; p:0.04). VRE growth was more frequent in mesenteric lymph nodes for Groups I (67%) and III (38%) than for Groups II (13%) and IV (none) (p:0.002). LPS was significantly higher in systemic blood of Group I (9.761±13.804 EU/mL−p:0.01). No differences for endotoxin occurred in portal blood. Conclusion –We developed a model of rats colonized with resistant bacteria useful to study intestinal translocation. Translocation occurred in surgical procedures with and without hepatic ischemia-reperfusion and probably occurred via the bloodstream. Translocation was probably lymphatic in the ischemia-reperfusion groups. Systemic blood endotoxin levels were higher in the group with complete hepatic ischemia.